[1]
|
Hilker, R., Poetter, C., Findeisen, N., et al. (2003) Nosocomial Pneumonia after Acute Stroke: Implications for Neuro-logical Intensive Care Medicine. Stroke, 34, 975-981. https://doi.org/10.1161/01.STR.0000063373.70993.CD
|
[2]
|
Smith, C.J., Kishore, A.K., Vail, A., Chamorro, A., Garau, J., Hopkins, S.J., et al. (2015) Diagnosis of Stroke-Associated Pneumonia: Recommendations from the Pneumo-nia in Stroke Consensus Group. Stroke, 46, 2335-2340.
https://doi.org/10.1161/STROKEAHA.115.009617
|
[3]
|
Westendorp, W.F., et al. (2022) Immunodepression, In-fections, and Functional Outcome in Ischemic Stroke. Stroke, 53, 1438-1448. https://doi.org/10.1161/STROKEAHA.122.038867
|
[4]
|
Sellars, C., Bowie, L., Bagg, J., et al. (2007) Risk Factors for Chest Infection in Acute Stroke: A Prospective Cohort Study. Stroke, 38, 2284-2291. https://doi.org/10.1161/STROKEAHA.106.478156
|
[5]
|
Song, T.J. and Kim, J. (2019) Risk of Post-Stroke Pneu-monia with Proton Pump Inhibitors, H2 Receptor Antagonists and Mucoprotective Agents: A Retrospective Nationwide Cohort Study. PLOS ONE, 14, e0216750.
https://doi.org/10.1371/journal.pone.0216750
|
[6]
|
Momosaki, R., Yasunaga, H., Matsui, H., Fushimi, K. and Abo, M. (2016) Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists and Risk of Pneumonia in Patients with Acute Stroke. Journal of Stroke and Cerebrovascular Diseases, 25, 1035-1040. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.01.018
|
[7]
|
Cieplik, F., Wiedenhofer, A.M., Pietsch, V., et al. (2020) Oral Health, Oral Microbiota, and Incidence of Stroke-Associated Pneumonia—A Prospective Observational Study. Frontiers in Neurology, 11, Article ID: 528056.
https://doi.org/10.3389/fneur.2020.528056
|
[8]
|
Qaryouti, D. and Greene-Chandos, D. (2023) Neurocritical Care Aspects of Ischemic Stroke Management. Critical Care Clinics, 39, 55-70. https://doi.org/10.1016/j.ccc.2022.07.005
|
[9]
|
Curtin, C., et al. (2023) Exploring Facilitators and Barriers Associ-ated with Oral Care for Inpatients with Dysphagia Post-Stroke. Gerodontology.
|
[10]
|
Wei, J., Huang, Z., Feng, Y.-Y., et al. (2020) A Comparative Study of Two Tube Feeding Methods in Patients with Dysphagia after Stroke: A Randomized Controlled Trial. Journal of Stroke and Cerebrovascular Diseases, 29, Article ID: 104602. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.104602
|
[11]
|
Labeit, B., et al. (2023) Diagnostics and Treatment of Post-Stroke Dysphagia. Der Nervenarzt, 94, 676-683.
https://doi.org/10.1007/s00115-023-01483-7
|
[12]
|
Pacheco-Castilho, A.C., Vanin, G.M., Dantas, R.O., Pon-tes-Neto, O.M. and Martino, R. (2019) Dysphagia and Associated Pneumonia in Stroke Patients from Brazil: A System-atic Review. Dysphagia, 34, 499-520.
https://doi.org/10.1007/s00455-019-10021-0
|
[13]
|
Zawiah, M., et al. (2023) Neutrophil-Lymphocyte Ratio, Mono-cyte-Lymphocyte Ratio, and Platelet-Lymphocyte Ratio in Stroke-Associated Pneumonia: A Systematic Review and Me-ta-Analysis. Current Medical Research and Opinion, 39, 475-482. https://doi.org/10.1080/03007995.2023.2174327
|
[14]
|
Labeit, B., et al. (2023) The Assessment of Dysphagia after Stroke: State of the Art and Future Directions. The Lancet Neurology, 22, 858-870. https://doi.org/10.1016/S1474-4422(23)00153-9
|
[15]
|
Verdecchia, P., Cavallini, C., Spanevello, A. and Angeli, F. (2020) The Pivotal Link between ACE2 Deficiency and SARS-CoV-2 Infection. European Journal of Internal Medicine, 76, 14-20. https://doi.org/10.1016/j.ejim.2020.04.037
|
[16]
|
Finlayson, O., Kapral, M., Hall, R., et al. (2011) Risk Factors, Inpatient Care, and Outcomes of Pneumonia after Ischemic Stroke. Neurology, 77, 1338-1345. https://doi.org/10.1212/WNL.0b013e31823152b1
|
[17]
|
Eltringham, S.A., Kilner, K., Gee, M., et al. (2018) Impact of Dysphagia Assessment and Management on Risk of Stroke-Associated Pneumonia: A Systematic Review. Cerebro-vascular Diseases, 46, 99-107.
https://doi.org/10.1159/000492730
|
[18]
|
Eltringham, S.A., Kilner, K., Gee, M., et al. (2020) Factors Associated with Risk of Stroke-Associated Pneumonia in Patients with Dysphagia: A Systematic Review. Dysphagia, 35, 735-744. https://doi.org/10.1007/s00455-019-10061-6
|
[19]
|
Zhao, D., Zhu, J. and Hu, K. (2020) Stroke Associated Pneumo-nia and Stroke Induced Immunosuppression. Chinese Journal of Internal Medicine, 59, 395-399.
|
[20]
|
Meisel, C., Schwab, J.M., Prass, K., et al. (2005) Central Nervous System Injury-Induced Immune Deficiency Syndrome. Nature Reviews Neuroscience, 6, 775-786. https://doi.org/10.1038/nrn1765
|
[21]
|
Liu, D.D., Chu, S.F., Chen, C., Yang, P.F., Chen, N.H. and He, X. (2018) Research Progress in Stroke-Induced Immunodepression Syndrome (SIDS) and Stroke-Associated Pneumonia (SAP). Neurochemistry International, 114, 42-54. https://doi.org/10.1016/j.neuint.2018.01.002
|
[22]
|
Patel, U.K., Kodumuri, N., Dave, M., et al. (2020) Stroke-Associated Pneumonia: A Retrospective Study of Risk Factors and Outcomes. Neurologist, 25, 39-48. https://doi.org/10.1097/NRL.0000000000000269
|
[23]
|
Sung, K.-L., et al. (2023) High Neutrophil-to-Lymphocyte Ratio Predicts One-Year Risk of Pneumonia Post-Stroke Discharge. Cerebrovascular Diseases (Basel, Switzerland), 52, 567-574. https://doi.org/10.1159/000529531
|
[24]
|
Wang, R.-H., et al. (2023) The Clinical Value of Neutro-phil-to-Lymphocyte Ratio (NLR), Systemic Immune-Inflammation Index (SII), Platelet-to-Lymphocyte Ratio (PLR) and Systemic Inflammation Response Index (SIRI) for Predicting the Occurrence and Severity of Pneumonia in Patients with Intracerebral Hemorrhage. Frontiers in Immunology, 14, Article ID: 1115031. https://doi.org/10.3389/fimmu.2023.1115031
|
[25]
|
Schweizer, J., Bustamante, A., Lapierre-Fétaud, V., et al. (2020) SAA (Serum Amyloid A): A Novel Predictor of Stroke-Associated Infections. Stroke, 51, 3523-3530. https://doi.org/10.1161/STROKEAHA.120.030064
|
[26]
|
Bustamante, A., García-Berrocoso, T., Penalba, A., et al. (2017) Sepsis Biomarkers Reprofiling to Predict Stroke-Associated Infections. Journal of Neuroimmunology, 312, 19-23. https://doi.org/10.1016/j.jneuroim.2017.08.012
|
[27]
|
Hoffmann, S., Harms, H., Ulm, L., et al. (2017) Stroke-Induced Immunodepression and Dysphagia Independently Predict Stroke-Associated Pneumonia—The PREDICT Study. Journal of Cerebral Blood Flow & Metabolism, 37, 3671-3682. https://doi.org/10.1177/0271678X16671964
|
[28]
|
Jin, R., Liu, S., Wang, M., Zhong, W. and Li, G. (2019) Inhibi-tion of CD147 Attenuates Stroke-Associated Pneumonia through Modulating Lung Immune Response in Mice. Frontiers in Neurology, 10, Article No. 853.
https://doi.org/10.3389/fneur.2019.00853
|
[29]
|
Ritzel, R.M., Al Mamun, A., Crapser, J., et al. (2019) CD200-CD200R1 Inhibitory Signaling Prevents Spontaneous Bacterial Infection and Promotes Resolution of Neuroin-flammation and Recovery after Stroke. Journal of Neuroinflammation, 16, Article No. 40. https://doi.org/10.1186/s12974-019-1426-3
|
[30]
|
Dirnagl, U., Klehmet, J., Braun, J.S., et al. (2007) Stroke-Induced Immunodepression: Experimental Evidence and Clinical Relevance. Stroke, 38, 770-773. https://doi.org/10.1161/01.STR.0000251441.89665.bc
|
[31]
|
Mracsko, E., Liesz, A., Karcher, S., Zorn, M., Bari, F. and Veltkamp, R. (2014) Differential Effects of Sympathetic Nervous System and Hypothalamic-Pituitary-Adrenal Axis on Systemic Immune Cells after Severe Experimental Stroke. Brain, Behavior, and Immunity, 41, 200-209. https://doi.org/10.1016/j.bbi.2014.05.015
|
[32]
|
Kim, H.S. (2021) Do an Altered Gut Microbiota and an Associated Leaky Gut Affect COVID-19 Severity? mBio, 12, e03022-20. https://doi.org/10.1128/mBio.03022-20
|
[33]
|
Stanley, D., Mason, L.J., Mackin, K.E., et al. (2016) Translocation and Dissemination of Commensal Bacteria in Post-Stroke In-fection. Nature Medicine, 22, 1277-1284. https://doi.org/10.1038/nm.4194
|
[34]
|
Li, D.Z., et al. (2023) Association between Malnutrition and Stroke-Associated Pneumonia in Patients with Ischemic Stroke. BMC Neurology, 23, Article No. 290. https://doi.org/10.1186/s12883-023-03340-1
|
[35]
|
Prass, K., Meisel, C., Höflich, C., et al. (2003) Stroke-Induced Immunodeficiency Promotes Spontaneous Bacterial Infections and Is Mediated by Sympathetic Activa-tion Reversal by Poststroke T Helper Cell Type 1-Like Immunostimulation. Journal of Experimental Medicine, 198, 725-736. https://doi.org/10.1084/jem.20021098
|
[36]
|
Maier, I.L., Karch, A., Mikolajczyk, R., Bähr, M. and Liman, J. (2015) Effect of Beta-Blocker Therapy on the Risk of Infections and Death after Acute Stroke—A Historical Cohort Study [Published Correction Appears in PLOS ONE. 2015; 10(3): e0121940]. PLOS ONE, 10, e0116836. https://doi.org/10.1371/journal.pone.0116836
|
[37]
|
Kishore, A.K., Jeans, A.R., Garau, J., et al. (2019) Antibiotic Treatment for Pneumonia Complicating Stroke: Recommendations from the Pneumonia in Stroke Consensus (PISCES) Group. European Stroke Journal, 4, 318-328.
https://doi.org/10.1177/2396987319851335
|
[38]
|
Shen, H. and Zhan, B. (2020) Effect of Vitamin E on Stroke-Associated Pneumonia. Journal of International Medical Research, 48. https://doi.org/10.1177/0300060520949657
|
[39]
|
Huang, Y.-W., et al. (2023) Systemic Inflammation Response In-dex as a Clinical Outcome Evaluating Tool and Prognostic Indicator for Hospitalized Stroke Patients: A Systematic Re-view and Meta-Analysis. European Journal of Medical Research, 28, Article No. 474. https://doi.org/10.1186/s40001-023-01446-3
|